Important medical disclaimer: This article provides general educational information about CGRP medications for migraine. It is not medical advice. Only a qualified healthcare provider can determine whether CGRP medications are appropriate for your specific situation, prescribe them, and monitor your treatment. Never start, stop, or change any medication without consulting your doctor.
CGRP medications for migraine represent the biggest advance in migraine treatment in over 30 years. The class targets a specific protein called calcitonin gene-related peptide that plays a central role in migraine attacks. Unlike older treatments that were repurposed from other conditions, CGRP medications were designed specifically for migraine from the ground up.
For people with chronic migraine — 15 or more headache days per month — CGRP medications have changed lives. Patients who tried 5 or 6 preventive medications without success often find meaningful relief on CGRP treatment. The medications also work for episodic migraine when other preventives fail or cause intolerable side effects.
This guide covers how CGRP medications work, the differences between preventive and abortive types, who they may help most, and what to discuss with your doctor before starting treatment. The goal is to help you have an informed conversation with your healthcare provider rather than diagnosing or treating yourself.
If you are still tracking your migraines to identify patterns, our migraine headache diary app guide covers tools that help. Our top migraine triggers guide covers the trigger identification work that often comes before considering preventive medication.
What CGRP Is and Why It Matters
CGRP stands for calcitonin gene-related peptide. It is a protein the body produces naturally. CGRP plays roles in pain transmission, blood vessel dilation, and inflammation throughout the body.
CGRP’s role in migraine.
During a migraine attack, CGRP levels rise significantly. The elevated CGRP contributes to the pain signaling, inflammation, and blood vessel changes that produce the migraine symptoms. Researchers identified this connection in the 1980s. Developing medications that target CGRP took another 30 years.
How CGRP medications work.
CGRP medications either block CGRP itself or block the receptor where CGRP attaches to nerve cells. Either approach reduces CGRP’s ability to trigger or sustain a migraine attack. The medications do not eliminate migraines for most people, but reduce frequency and severity meaningfully.
The targeted mechanism explains why side effects are typically milder than those of older migraine medications. Older preventives often work through brain-wide effects on neurotransmitters, blood pressure, or seizure thresholds. CGRP medications affect a single, specific protein — fewer body systems involved, fewer side effects to manage.
The Two Categories of CGRP Medications
CGRP medications come in two main categories with different uses. Understanding which category fits which need is important for productive conversations with your doctor.
Preventive CGRP medications.
Preventive CGRP medications are taken regularly to reduce the frequency of migraine attacks. They do not treat individual attacks once they start. They reduce how often attacks happen overall.
Most preventive CGRP medications are injectable monoclonal antibodies given monthly or quarterly. The injection delivers an antibody that binds to either CGRP or its receptor. The binding lasts for weeks, providing ongoing protection between doses.
The current FDA-approved preventive CGRP medications include erenumab (Aimovig), fremanezumab (Ajovy), galcanezumab (Emgality), and eptinezumab (Vyepti). The first three are self-administered injections. Eptinezumab is given as an IV infusion at a clinic every 3 months.
Oral preventive CGRP medications also exist. Atogepant (Qulipta) and rimegepant (Nurtec ODT, used preventively) provide preventive benefits without injections. These are smaller molecules that block CGRP receptors rather than antibodies that bind to CGRP.
Abortive CGRP medications.
Abortive CGRP medications are taken to stop a migraine attack once it starts. They serve the same general purpose as triptans — drugs taken at the start of an attack to abort it before it becomes severe.
The current FDA-approved abortive CGRP medications include rimegepant (Nurtec ODT) and ubrogepant (Ubrelvy). Both are oral tablets. Rimegepant is also approved for preventive use at a different dosing schedule.
Abortive CGRP medications offer an alternative for people who cannot take triptans because of cardiovascular concerns. Triptans cause blood vessel constriction that increases risks for people with a history of heart disease, stroke, or uncontrolled high blood pressure. CGRP medications do not have this constriction effect, making them safer for cardiovascular patients.
Who CGRP Medications May Help Most
CGRP medications are not appropriate for everyone with migraine. Insurance coverage, side effect profiles, and overall effectiveness vary significantly between individuals. Some patient profiles tend to benefit more than others.
Chronic migraine patients.
A chronic migraine — defined as 15 or more headache days per month for at least 3 months, with at least 8 of those being migraines — is the strongest indication for CGRP medications. Another thing is that chronic migraine patients often have tried multiple preventive medications without adequate response. CGRP medications produce meaningful improvement in roughly 50 to 60 percent of these patients in clinical trials.
Patients who failed multiple preventives.
Patients who tried 2 or more older preventive medications (beta blockers, antidepressants, anti-seizure medications, Botox) without success often qualify for CGRP medications under insurance criteria. The “failed multiple preventives” qualification is built into most insurance approval processes.
Patients with cardiovascular contraindications to triptans.
Patients who cannot take triptans because of heart disease, stroke history, or uncontrolled high blood pressure have limited acute treatment options. Abortive CGRP medications fill this gap. The medications do not constrict blood vessels and do not carry the cardiovascular risks that triptans do.
Patients with medication overuse headache.
People who developed medication-overuse headache from using triptans or over-the-counter pain medications too frequently sometimes do well on CGRP preventives. The preventives reduce overall attack frequency, which reduces the need for acute medications and lets the medication overuse pattern resolve.
Common Side Effects and Considerations
CGRP medications generally have milder side effect profiles than older migraine preventives. Common side effects exist and are worth understanding before starting treatment.
Common side effects of preventive CGRP medications.
Injection site reactions — redness, soreness, or itching at the injection site — are the most common side effects of injectable CGRP medications. Reactions typically resolve within a few days and become milder with subsequent doses for most patients.
Constipation is reported across all preventive CGRP medications. Severity ranges from mild to severe. Some patients find the constipation manageable with hydration, fiber, and over-the-counter laxatives. Others find it severe enough to discontinue the medication.
Less common side effects include muscle cramps, hair thinning, hypertension, and Raynaud’s phenomenon. Anyone experiencing concerning symptoms after starting CGRP medications should contact their prescribing doctor.
Common side effects of abortive CGRP medications.
Abortive CGRP medications have generally mild side effects compared to triptans. Common effects include nausea, dizziness, drowsiness, and dry mouth. Most patients tolerate these without significant disruption to daily activities.
Long-term safety questions.
CGRP medications have been on the market since 2018 — long enough to track common short-term effects but shorter than older migraine medications with decades of safety data. Researchers continue monitoring long-term cardiovascular effects, fertility and pregnancy effects, and other questions that need years of post-market data to answer fully.
For pregnant or potentially pregnant patients, current guidance is generally to avoid CGRP medications until more pregnancy safety data is available. This is a discussion to have with both your neurologist and your obstetrician if relevant.
What to Ask Your Doctor
Productive conversations with your doctor about CGRP medications start with informed questions. The questions below cover the main decision points most patients face.
Am I a candidate for CGRP medications?
This is the foundation question. Your doctor will consider your migraine pattern, previous medication history, other health conditions, and insurance coverage. The answer is not always yes. Some patients are better candidates for other treatment approaches first.
Should I start with a preventive or abortive CGRP medication?
The answer depends on your migraine pattern. Patients with frequent migraines benefit most from preventives. Patients with infrequent but severe migraines who cannot tolerate triptans benefit most from abortives. Some patients use both — preventive monthly with abortive available for breakthrough attacks.
What is the expected timeline to see results?
Preventive CGRP medications typically show benefits within 2 to 3 months. Some patients respond after the first dose. Others need 3 to 4 doses before seeing the full effect. Setting realistic expectations prevents premature discontinuation.
Abortive CGRP medications work within hours of taking a dose for a specific attack. The “is this working” question gets answered for each attack rather than over months.
What does my insurance cover?
CGRP medications are expensive without insurance coverage. Monthly costs without insurance can run $700 to $1,000 per month for preventives. Most insurance plans cover CGRP medications but require prior authorization and proof of failed trials with older medications. Manufacturer copay assistance programs can reduce out-of-pocket costs significantly for patients with private insurance.
How long should I stay on the medication if it works?
Current recommendations vary. Some neurologists recommend continuing indefinitely if the medication works and is well-tolerated. Others recommend a treatment break after 12 to 18 months to assess whether continued treatment is necessary. This is a discussion to revisit with your doctor as your treatment continues.
CGRP Medications and Other Migraine Treatments
CGRP medications work best as part of a complete migraine management approach rather than a standalone solution.
Combining preventives and acute treatments.
Patients on preventive CGRP medications still need acute treatment for breakthrough migraines. Triptans, abortive CGRP medications, NSAIDs, and other acute treatments all remain appropriate alongside preventive CGRP medications. The preventive reduces attack frequency. The acute treatment handles the attacks that still occur.
Lifestyle approaches still matter.
Trigger identification, sleep hygiene, hydration, regular meals, and stress management all remain important even on CGRP medications. The medications reduce vulnerability to triggers but do not eliminate it. Patients who continue lifestyle work alongside CGRP medications typically see better results than those who rely on medication alone.
For lifestyle approaches that pair with medical treatment, our top migraine triggers guide and migraine food triggers list cover the trigger identification side. Our how to sleep with migraine guide covers the sleep approaches that reduce attack frequency.
Devices and supplements as complementary tools.
Migraine devices like Cefaly and supplements like magnesium can complement CGRP medication. They are not substitutes but can reduce overall reliance on medication when used appropriately. Discuss any supplement or device additions with your prescribing doctor to avoid interactions.
For information on these complementary tools, our Cefaly review and best magnesium supplements for migraine prevention guides cover specific options.
Quick Reference: CGRP Medications Currently FDA-Approved
| Medication | Brand Name | Type | Dosing |
|---|---|---|---|
| Erenumab | Aimovig | Preventive injection | Monthly |
| Fremanezumab | Ajovy | Preventive injection | Monthly or quarterly |
| Galcanezumab | Emgality | Preventive injection | Monthly |
| Eptinezumab | Vyepti | Preventive IV infusion | Quarterly |
| Atogepant | Qulipta | Preventive oral | Daily |
| Rimegepant | Nurtec ODT | Preventive or abortive oral | Varies |
| Ubrogepant | Ubrelvy | Abortive oral | Per attack |
This list reflects FDA approvals current at the time of writing. New CGRP medications continue entering clinical trials and reaching the market. Your neurologist will have the most current information on available options.
Our Take
CGRP medications represent the most significant advance in migraine treatment in decades. For chronic migraine patients and those who have failed multiple older preventives, the medications offer real hope where previous options often disappointed. The targeted mechanism produces meaningful improvement for roughly half of patients in clinical trials with side effect profiles generally milder than older alternatives.
The medications are not right for everyone. Insurance coverage requirements, individual response variation, side effect tolerability, and treatment cost all factor into the decision. The right approach is an informed conversation with a neurologist who can evaluate your specific situation against the current evidence.
If you are considering CGRP medications, write down your questions before your appointment. Bring your migraine diary if you keep one. Ask about both preventive and abortive options. Discuss insurance coverage and copay assistance programs. The goal is to make an informed decision together with your healthcare provider rather than going in unprepared.
For the bigger picture of migraine management, our best migraine relief products guide covers the over-the-counter and lifestyle tools that work alongside prescription treatments.
Frequently Asked Questions
What are CGRP medications for migraine?
CGRP medications are a class of drugs designed specifically for migraine treatment. They target a protein called calcitonin gene-related peptide that plays a central role in migraine attacks. The medications either block CGRP itself or block the receptor where CGRP attaches to nerve cells. Both approaches reduce CGRP’s ability to trigger or sustain migraine attacks. CGRP medications come in preventive forms taken regularly to reduce attack frequency and abortive forms taken to stop attacks once they start.
How long do CGRP medications take to work?
Preventive CGRP medications typically show benefits within 2 to 3 months of starting treatment. Some patients respond after the first dose. Others need 3 to 4 doses before seeing the full effect. Doctors generally recommend giving preventive medications a 3-month trial before deciding whether they are working. Abortive CGRP medications work within hours of taking a dose for a specific attack rather than building up over months.
Are CGRP medications safe?
CGRP medications have been on the market since 2018 and generally have milder side effect profiles than older migraine preventives. Common side effects include injection site reactions for injectable medications and constipation across most CGRP preventives. Long-term safety data continues to accumulate as more patients use the medications over the years. Pregnant patients and patients with certain cardiovascular conditions may need to avoid CGRP medications. Discuss your specific medical history with your doctor before starting any new medication.
Can I take CGRP medications and triptans together?
Yes, in many cases. Preventive CGRP medications are designed to reduce migraine frequency. Triptans treat individual attacks that still occur. The two work through different mechanisms and can be used together under medical supervision. Abortive CGRP medications and triptans serve similar acute treatment purposes, so they are typically not used for the same attack. Discuss specific combinations with your prescribing doctor to ensure the approach fits your situation.
How much do CGRP medications cost?
Without insurance, CGRP medications typically cost $700 to $1,000 per month for preventives. Abortive CGRP medications cost $50 to $90 per dose without insurance. Most insurance plans cover CGRP medications but require prior authorization and proof of failed trials with older medications. Manufacturer copay assistance programs can reduce out-of-pocket costs significantly for patients with commercial insurance. Patients without insurance or with Medicaid/Medicare have separate assistance program options worth asking your doctor or pharmacist about.
Final medical disclaimer: The information in this article is for educational purposes only. It does not constitute medical advice and should not be used as a substitute for professional medical care. Always consult with a qualified healthcare provider before starting, stopping, or changing any medication. Individual treatment decisions depend on factors only your doctor can fully evaluate.
